phosphotransferase which is produced by Escherichia coli K12 ML1629 and ML1410 R81
phosphorylates the 3'-hydroxyl group of kanamycins ( Fig. 1 A. The structure of the inactivated compounds was determined by the methods reported in previous papers1'3'4).
Weattempted to purify the enzyme by successive application of dialysis, ammonium sulfate precipitation, Sephadex G-100 column chromatograpy, and DEAE Sephadex A50 column chromatography as described for the isolation of a kanamycin phosphotransferase from Pseudomonas aeruginosa^. In the course of this study, we found that the present enzyme is very unstable. Dithiothreitol at 10mMpre-vented denaturation and restored the activity of the denaturated enzyme. Though these procedures gave only 3~4 fold purification as shown by activity per mg of protein, the kanamycin-inactivating and lividomycin-inactivating activities were always found in the same fraction.
Kanamycinphosphotransferase I was successfully purified by affinity chromatography6). We tried affinity chromatography with adsorbents containing BB-K8 or lividomycin A as the ligand. BB-K8 has an (S)-4-amino-2-hydroxybutyryl group which might be bound to cyanogen bromide-activated Sepharose 4B. Lividomycin A has a primary amino group, 6-amino group of 2, 6-diamino-L-idose, which was thought to exist far from the enzyme binding site. As shown below, we obtained more successful results with lividomycin A-Sepharose 4B. BB-K8-Sepharose 4B was prepared as follows: To 10 ml of Sepharose 4B (marketed by Pharmacia Fine Chemicals AB, Upsala, Sweden) was added 1.5 g of cyanogen bromide freshly dissolved in 10ml of distilled water; the pH was adjusted to ll.0 with 2n NaOH(8.0ml) and filtered. The cyanogen bromide-activated Sepharose 4B thus obtained was washed with 0.1 n sodium carbonate buffer at dH 10.5 in an ice-bath and
in 10ml of sodium carbonate buffer of pH 10.5 was added; after stirring overnight at 4°C, the BB-K8-Sepharose 4B was washed with 600ml of distilled water. Lividomycin A-Sepharose 4B was prepared as follows: cyanogen bromide-activated Sepharose 4B (9g, marketed by Pharmacia Fine Chemicals AB, Upsala, Sweden) was washed with 1,800ml of1mM HC1, 1,000ml of cold water, 50ml of 0.1m NaHCO3-0.5M NaCl successively and 1.0g of lividomycin A in 45ml of 0.1m NaHCO3-0.5m NaCl was added and the mixture was stirred at 4°C overnight; lividomycin A-Sepharose 4B thus prepared was treated with 300ml of 1.0mmono-ethanolamine hydrochloride (pH 8.0) and washed with 100ml of 0.1m acetate buffer-l.OM NaCl (pH4.0), 100ml of 0.1 m borate buffer-l.OM NaCl (pH8.0) and distilled water. CellsofE.
coli K12 J5 Rll-2 which were grown in 2.0 liters of a medium containing 1 % peptone, 0.5% meat extract, 0.3 % NaCl and 5^g/ml of kanamycin (pH7.4) for 6 hours at 34°C were collected by centrifugation at 8,000 rpm for 20 minutes, and washed with 20mM tris-HCl buffer of pH7.2 containing 10him dithiothreitol.. The cells (7.3 g) thus obtained were suspended in the same buffer (7.3 ml) and disrupted by passage through a French pressure cell (1,200 kg/cm2 NaCl (100 ml) in the tris-HCl buffer described above. Then, the enzyme which phosphorylated and inactivated both lividomycin A and kanamycin appeared in the eluate with 0.6m NaCl.
By this procedure, the enzyme was purified 25-fold in phosphorylating activity for both kanamycin and lividomycin A. The yield was 50^. The enzyme in 5ml of the supernatant was subjected to BB-K8-Sepharose 4B column chromatography in a similar way. In this case the enzyme was eluted with 0.1m NaCl, and was purified 9. 1-fold. The purification of the enzyme by lividomycin A-Sepharose 4B chromatography with a gradient ofNaCl from 0^0.8 m is shown in Fig. 2 . Using the enzyme purified by the affinity chromatography as described above (13.2 u/mg of kanamycin-inactivating activity, and 62.5 u/mg oflividomycin A-inactivating activity) , the effect ofkanamycin or lividomycin A on lividomycin A phosphorylation or on kanamycin phosphorylation was examined. The composition of the reaction mixture is shown in Table  1 . As shown in the Table, in the case ofkanamycin phosphorylation, 22^g (as protein) of the enzyme was added to 10ml of the reaction mixture and in the case of lividomycin A phosphorylation, 5.0 fig (as protein) of the enzyme was added. The reaction was stopped after incubation at 37°C for 1 hour by heating at 80°C for 3 minutes. After the reaction, the residual antibiotic which was not phosphorylated was determined.
First, it was adsorbed on an Amberlite CG50 (NH4+, 1.0ml) column and eluted with 4.0ml of 2n NH4OH, then the eluate was passed through Dowex 1 x2 (OH", 0.5ml) resin, and dried to a powder under vacuum. The powder thus obtained was dissolved in 0.14^0.18ml of distilled water, and the residual antibiotic was determined by high pressure liquid chromatography (Varian LC4200, under 3350 psi, at 50°C, at the flow rate of 15ml of water/hr) using a column of Table  1 , 100 % ofkanamycin or 80 % of lividomycin A which was added was phosphorylated. Addition of2X 10~4 m kanamycin to the lividomycin Ribostamycin contains two hydroxyl groups, that is, 3-hydroxyl group of2, 6-diamino-2, 6-dideoxy-D-glucose moiety and 5-hydroxyl group of ribose moiety which can be phosphorylated by this enzyme. Building the model, we found these hydroxyl groups are located close to each other, as shown in Fig. 3 . Thus, in the enzyme reaction, the terminal phosphorous atom of ATP is thought to be located close to both hydroxyl groups. It may be closer to the Vhydroxyl because the reaction product from ribostamycin was found to be ribostamycin Vphosphate.
But, the enzyme reaction on V', 4/-dideoxyribostamycin which was synthesized from ribostamycin8) and lacks the 3/-hydroxyl group, gave 3', 4/-dideoxyribostamycin 5"-phosphate in which the 5-hydroxyl group of ribose moiety was phosphorylated. Confirming this fact, strains such as E. coli K12 ML1629, E. coli K12 ML1410 R81 and E. coli K12 J5
Rl1-2 carrying R factor producing kanamycin phosphotransferase I are resistant to ribostamycin and 3', 4'-dideoxyribostamycin.
E. coli JR66/W677 which produces kanamycin phosphotransferase II is resistant to ribostamycin but sensitive to lividomycins and 3', 4'-dideoxyribostamycin.
We confirmed that kanamycin phosphotransferase II does not phosphorylate 
